Unbalanced risk-benefit analysis of ADHD drugs - Authors' reply.

Cipriani, Andrea; Adamo, Nicoletta; Del Giovane, Cinzia; Coghill, David; Banaschewski, Tobias; Hollis, Chris; Zuddas, Alessandro; Simonoff, Emily; Cortese, Samuele (2018). Unbalanced risk-benefit analysis of ADHD drugs - Authors' reply. The Lancet. Psychiatry, 5(11), pp. 871-873. Elsevier 10.1016/S2215-0366(18)30396-1

[img] Text
Cipriani LancetPsychiatry 2018_correspondence.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (50kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Medical Education > Institute of General Practice and Primary Care (BIHAM)

UniBE Contributor:

Del Giovane, Cinzia

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

2215-0374

Publisher:

Elsevier

Language:

English

Submitter:

Doris Kopp Heim

Date Deposited:

15 Nov 2018 08:58

Last Modified:

24 Oct 2019 12:35

Publisher DOI:

10.1016/S2215-0366(18)30396-1

PubMed ID:

30401441

BORIS DOI:

10.7892/boris.121248

URI:

https://boris.unibe.ch/id/eprint/121248

Actions (login required)

Edit item Edit item
Provide Feedback